US Patent 6913915 PEG-modified uricase
Patent 6913915 was granted and assigned to PHOENIX PHARMACOLOGICS, INC. on July, 2005 by the United States Patent and Trademark Office.
All edits
Edits on 23 Oct, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 15 May, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Edits on 22 Oct, 2023
Golden AI
Edits made to:
Infobox (+12 properties)
Article (+267 characters)
Article
Patent abstract
The present invention is directed to uricase modified with polyethylene glycol and to methods of treating different illnesses characterized by increased circulating uric acid levels, including but not limited to, hyperuricemia and tumor lysis syndrome.
Infobox
Is a
Patent Applicant
0
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Charles Mark Ensor0
Frederick Wayne Holtsberg0
Mike A. Clark0
Date of Patent
July 5, 2005
0Patent Application Number
099213800
Date Filed
August 2, 2001
0Patent Primary Examiner
Golden AI
Edits made to:
US Patent 6913915 PEG-modified uricase
Find more entities like US Patent 6913915 PEG-modified uricase
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
